| Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma H Yang, W Hu, W Wang, P Chen, W Ding, W Luo International Journal of Radiation Oncology* Biology* Physics 85 (1), e47-e54, 2013 | 174 | 2013 |
| Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma W Wang, H Yang, W Hu, G Shan, W Ding, C Yu, B Wang, X Wang, Q Xu International Journal of Radiation Oncology* Biology* Physics 77 (2), 617-621, 2010 | 168 | 2010 |
| Lipoprotein (a) level and its association with tumor stage in male patients with primary lung cancer H Yang, X Chen, W Hu, D Lv, W Ding, L Tang, J Jiang, M Ye Clinical chemistry and laboratory medicine 47 (4), 452-457, 2009 | 58 | 2009 |
| Weekly paclitaxel with concurrent radiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma W Hu, W Ding, H Yang, M Shao, B Wang, J Wang, S Wu, S Wu, L Jin, ... Radiotherapy and Oncology 93 (3), 488-491, 2009 | 36 | 2009 |
| Increased expression of O-GlcNAc transferase (OGT) is a biomarker for poor prognosis and allows tumorigenesis and invasion in colon cancer D Xu, W Wang, T Bian, W Yang, M Shao, H Yang International Journal of Clinical and Experimental Pathology 12 (4), 1305, 2019 | 32 | 2019 |
| Changes of the transverse diameter and volume and dosimetry before the 25th fraction during the course of intensity-modulated radiation therapy (IMRT) for patients with … H Yang, W Hu, W Ding, G Shan, W Wang, C Yu, B Wang, M Shao, J Wang, ... Medical Dosimetry 37 (2), 225-229, 2012 | 27 | 2012 |
| Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients Y Meng, H Yang, W Wang, X Tang, C Jiang, Y Shen, W Luo Radiation Oncology 14, 1-8, 2019 | 26 | 2019 |
| Rules of parotid gland dose variations and shift during intensity modulated radiation therapy for nasopharyngeal carcinoma W Wang, H Yang, Y Mi, W Hu, W Ding, Y Xie, Y Cai, X Chen Radiation Oncology 10, 1-6, 2015 | 22 | 2015 |
| GBP1 facilitates indoleamine 2, 3-dioxygenase extracellular secretion to promote the malignant progression of lung cancer Y Meng, W Wang, M Chen, K Chen, X Xia, S Zhou, H Yang Frontiers in Immunology 11, 622467, 2021 | 21 | 2021 |
| Adaptive intensity-modulated radiotherapy with simultaneous integrated boost for stage III non-small cell lung cancer: Is a routine adaptation beneficial? Y Meng, W Luo, H Xu, W Wang, S Zhou, X Tang, Z Li, C Zhou, H Yang Radiotherapy and Oncology 158, 118-124, 2021 | 19 | 2021 |
| Enhanced CT-based radiomics to predict micropapillary pattern within lung invasive adenocarcinoma Y Xu, W Ji, L Hou, S Lin, Y Shi, C Zhou, Y Meng, W Wang, X Chen, ... Frontiers in Oncology 11, 704994, 2021 | 17 | 2021 |
| High PHLPP expression is associated with better prognosis in patients with resected lung adenocarcinoma D Lv, H Yang, W Wang, Y Xie, W Hu, M Ye, X Chen BMC cancer 15, 1-6, 2015 | 17 | 2015 |
| Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis X Zhou, W Wang, C Zhou, J Zhu, W Ding, M Chen, K Chen, Y Shi, X Chen, ... Radiotherapy and Oncology 170, 136-142, 2022 | 16 | 2022 |
| Reduced PHLPP expression leads to EGFR-TKI resistance in lung cancer by activating PI3K-AKT and MAPK-ERK dual signaling W Wang, X Xia, K Chen, M Chen, Y Meng, D Lv, H Yang Frontiers in Oncology 11, 665045, 2021 | 15 | 2021 |
| NADPH Oxidase-derived ROS promote mitochondrial alkalization under salt stress in Arabidopsis root cells Y Sun, W Liang, H Cheng, H Wang, D Lv, W Wang, M Liang, C Miao Plant Signaling & Behavior 16 (3), 1856546, 2021 | 14 | 2021 |
| Increased cerebellar–default-mode network connectivity at rest in obsessive–compulsive disorder D Lv, Y Ou, Y Chen, R Yang, Z Zhong, C Jia, L Sun, Y Wang, G Zhang, ... European Archives of Psychiatry and Clinical Neuroscience 270, 1015-1024, 2020 | 13 | 2020 |
| Intermediate dose-volume parameters, not low-dose bath, is superior to predict radiation pneumonitis for lung cancer treated with intensity-modulated radiotherapy Y Meng, W Luo, W Wang, C Zhou, S Zhou, X Tang, L Hou, FMS Kong, ... Frontiers in oncology 10, 584756, 2020 | 13 | 2020 |
| Phase I study of icotinib, an EGFR tyrosine kinase inhibitor combined with IMRT in nasopharyngeal carcinoma W Hu, W Wang, P Yang, C Zhou, W Yang, B Wu, H Lu, H Yang International Journal of Clinical and Experimental Medicine 8 (9), 15675, 2015 | 13 | 2015 |
| Endostar improved efficacy of concurrent chemoradiotherapy with vinorelbine plus carboplatin in locally advanced lung squamous cell carcinoma patients with high serum Lp (a … H Xu, D Lv, Y Meng, M Wang, W Wang, C Zhou, S Zhou, X Chen, H Yang Annals of Palliative Medicine 9 (2), 29807-29307, 2020 | 12 | 2020 |
| USP46 inhibits cell proliferation in lung cancer through PHLPP1/AKT pathway W Wang, M Chen, H Xu, D Lv, S Zhou, H Yang BioMed Research International 2020 (1), 2509529, 2020 | 12 | 2020 |
